News out and this board is quiet today. That's odd
SAN DIEGO, July 9, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the company and its subsidiaries Kannaway® and HempMeds® had their largest-ever (unaudited) sales bookings month in the Company's history in June 2019. The Company also reached major milestones in its business operations.
"As we approach the mid-year mark, we are thrilled to see our growth in 2019 continue," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "Our success can be attributed to the company's new management group from March 2016, handling both the Kannaway division as well as overall company-wide operations. This new team has grown monthly revenue 15 times compared to March 2016 revenue. We optimistically look at continued growth as operational activities expand into new markets during the second half of the year."
The Company also achieved significant accomplishments during the month of June, including completing the first-ever high-level stability study on a CBD hemp oil product, its subsidiary HempMeds® adding new products to its established Personal Care Line, its subsidiary Dixie Botanicals® launching a CBD sunscreen in partnership with Surface Products Corp., and its subsidiary Kannaway® becoming a member of the European Industrial Hemp Association. Kannaway® also began pre-marketing initiatives in Japan ahead of its predicted substantial growth there.
